[Side-effects of triamcinolone in young patients].
METHODS
Intravitreal triamcinolone is being increasingly employed for the treatment of macular diseases. We report two cases of intraocular pressure elevation and cataract formation after intravitreal triamcinolone therapy, and wonder if these complications are more likely when this agent is used in young patients. Intravitreal triamcinolone was injected into both eyes of the two young patients with chronic posterior and intermediate uveitis refractory to peribulbar and oral corticosteroid therapy. Chronic cystoid macular edema improved in both patients, however the intraocular pressure increased, requiring topical antihypertensive therapy, and this was followed by accelerated cataract formation.


CONCLUSIONS
Young age and chronic inflammation could be associated with an intraocular pressure rise and subsequent cataract development after intravitreal triamcinolone.
Suárez-Figueroa
M
M
Hospital Ramón y Cajal, Madrid, España.
Contreras
I
I
Noval
S
S
D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D002386:Cataract / Q000139:chemically induced*; D005260:Female; D006801:Humans; D009798:Ocular Hypertension / Q000139:chemically induced*; D014221:Triamcinolone / Q000009:adverse effects*; D014605:Uveitis / Q000188:drug therapy
D000893:Anti-Inflammatory Agents; D014221:Triamcinolone